- Home
- CSBR
as of 01-27-2026 4:00pm EST
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | BALTIMORE |
| Market Cap: | 98.5M | IPO Year: | 1986 |
| Target Price: | $12.00 | AVG Volume (30 days): | 5.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.59 - $11.99 | Next Earning Date: | 03-10-2026 |
| Revenue: | $58,424,000 | Revenue Growth: | 9.06% |
| Revenue Growth (this year): | 4.84% | Revenue Growth (next year): | 11.51% |
AI-Powered CSBR Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare CSBR vs Leading Stocks
See how CSBR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CSBR Champions Oncology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.